GLP-1 for Men: Targeting Visceral Fat and Metabolic Health

At a glance

• Men tend to accumulate fat around the abdomen — the classic "beer belly" or "dad bod." This isn't just subcutaneous fat (under the skin).
• Much of it is visceral fat: fat that wraps around internal organs including the liver, pancreas, and intestines.
• Visceral fat is metabolically active.

Why Visceral Fat Matters for Men

Men tend to accumulate fat around the abdomen — the classic "beer belly" or "dad bod." This isn't just subcutaneous fat (under the skin). Much of it is visceral fat: fat that wraps around internal organs including the liver, pancreas, and intestines.

Visceral fat is metabolically active. It releases inflammatory compounds and hormones that directly contribute to(Based on clinical guidelines and prescribing information):

• Cardiovascular disease — Heart attack, stroke, atherosclerosis
• Type 2 diabetes — Insulin resistance and impaired glucose metabolism
• Metabolic syndrome — The dangerous cluster of high blood pressure, high blood sugar, abnormal cholesterol, and abdominal obesity
• Fatty liver disease — Non-alcoholic fatty liver disease (NAFLD) affects an estimated 25–30% of Hong Kong adults(Based on clinical guidelines and prescribing information)
• Reduced testosterone — Visceral fat converts testosterone to oestrogen via aromatase, creating a vicious cycle of weight gain and hormonal disruption(Based on clinical guidelines and prescribing information)

A man with a normal BMI but a large waist circumference may be at higher cardiometabolic risk than someone with a higher BMI but less central fat(Based on clinical guidelines and prescribing information).

How GLP-1 Medications Target Visceral Fat

GLP-1 receptor agonists don't just reduce total body weight — they preferentially reduce visceral fat and improve body composition:

Mechanism of Action

GLP-1 works through multiple pathways relevant to visceral fat (Drucker DJ. Cell Metab. 2018;27(4):740-756. PMID: 29617641):

1. Central appetite regulation — Reduces overall caloric intake by acting on hypothalamic hunger centres
2. Hepatic effects — Reduces liver fat accumulation and improves hepatic insulin sensitivity(Based on clinical guidelines and prescribing information)
3. Inflammation reduction — Lowers systemic inflammatory markers associated with visceral adiposity(Based on clinical guidelines and prescribing information)
4. Improved insulin signalling — Better insulin function helps redirect energy away from visceral fat storage

What the Trials Show for Men

In the STEP 1 trial, male participants receiving semaglutide 2.4 mg showed significant reductions in waist circumference — a proxy measure for visceral fat (Wilding JPH et al. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185).

In the SURMOUNT-1 trial, tirzepatide produced even larger waist-circumference reductions across all dose groups (Jastreboff AM et al. N Engl J Med. 2022;387(3):205-216. PMID: 35658024).

Imaging studies using DEXA scans and MRI have confirmed that GLP-1 treatment preferentially reduces visceral fat relative to subcutaneous fat(Based on clinical guidelines and prescribing information).

Beyond Fat Loss: Health Benefits for Men

Cardiovascular Protection

Visceral fat loss translates directly to cardiovascular risk reduction: - Lower blood pressure(Based on clinical guidelines and prescribing information) - Improved lipid profile (lower triglycerides, higher HDL)(Based on clinical guidelines and prescribing information) - Reduced arterial inflammation(Based on clinical guidelines and prescribing information)

The SELECT trial demonstrated that semaglutide reduced major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in patients with overweight/obesity and established cardiovascular disease(Based on clinical guidelines and prescribing information).

Metabolic Improvement

• Blood sugar: Even in men without diabetes, GLP-1 medications improve insulin sensitivity and glucose regulation(Based on clinical guidelines and prescribing information)
• Fatty liver: Significant reductions in liver fat content, with some patients achieving resolution of NAFLD(Based on clinical guidelines and prescribing information)
• Metabolic syndrome: Improvements across all five criteria of metabolic syndrome(Based on clinical guidelines and prescribing information)

Testosterone and Sexual Health

The relationship between obesity and testosterone is bidirectional: - Excess visceral fat → lower testosterone (via aromatase conversion) - Lower testosterone → increased fat storage → more visceral fat

Weight loss through GLP-1 medication can break this cycle. Studies show that significant weight loss (>10% body weight) is associated with meaningful increases in testosterone levels(Based on clinical guidelines and prescribing information).

This has downstream effects on: - Energy and vitality - Muscle mass maintenance - Sexual function - Mood and cognitive clarity

GLP-1 and Exercise for Men

For optimal results, GLP-1 medication should be combined with a structured exercise programme:

Resistance Training (3–4 Times Per Week)

• Critical for preserving muscle mass during weight loss
• Focus on compound movements: squats, deadlifts, bench press, rows
• Progressive overload: gradually increase weight or reps
• Muscle tissue is metabolically active — more muscle means higher resting metabolic rate

Cardiovascular Exercise (3–5 Times Per Week)

• Moderate intensity: brisk walking, cycling, swimming
• 150–300 minutes per week
• Particularly effective for visceral fat reduction when combined with GLP-1(Based on clinical guidelines and prescribing information)

Protein Intake

• Aim for 1.2–1.6 g protein per kg body weight per day(Based on clinical guidelines and prescribing information)
• Distribute evenly across meals
• Prioritise lean meats, fish, eggs, dairy, legumes
• Consider protein supplementation if struggling to meet targets due to reduced appetite

Addressing the Stigma

Many Hong Kong men avoid seeking help for weight management due to: - Perception that weight loss is "not a men's issue" - Reluctance to visit clinics for what they see as a cosmetic concern - Lack of awareness that abdominal obesity is a serious medical risk - Cultural norms around body image for men

The reality: obesity is a medical condition with serious health consequences. GLP-1 treatment is evidence-based medicine, not vanity. And with noah™'s online platform, you don't need to sit in a waiting room to get help.

The noah™ Approach for Men

noah™ provides discreet, doctor-led weight management designed to fit into a busy professional life:

• No clinic visits required — Everything from consultation to delivery happens online
• Discreet packaging — No one needs to know what's inside
• Evidence-based protocols — Your treatment is guided by clinical data, not trends
• Male-specific considerations — Our doctors understand the metabolic differences and health priorities relevant to men

Frequently Asked Questions

1. Does GLP-1 medication affect testosterone levels?

GLP-1 medications do not directly affect testosterone. However, the weight loss they produce — particularly visceral fat loss — is associated with increased testosterone levels in men(Based on clinical guidelines and prescribing information).

2. Can I build muscle while on GLP-1 medication?

Yes, though it requires deliberate effort. Adequate protein intake and consistent resistance training are essential. Some patients find it challenging to eat enough protein due to reduced appetite — planning meals around protein sources helps.

3. Will GLP-1 affect my gym performance?

During the initial dose-escalation phase, reduced caloric intake and GI side effects may temporarily affect energy levels. Most men find they adapt within a few weeks. Timing your injection and meals around workouts can help.

4. Is the medication safe with supplements I'm taking?

Inform your noah™ doctor about all supplements, including protein powders, creatine, pre-workout formulas, and vitamins. Most common supplements are compatible, but your doctor should be aware of everything you're taking.

5. How is this different from testosterone replacement therapy?

GLP-1 medication addresses the root cause of low testosterone in overweight men (excess visceral fat) rather than replacing the hormone directly. For men with clinically low testosterone due to other causes, TRT may still be appropriate — this should be discussed with your doctor.

References

1. Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018;27(4):740-756. PMID: 29617641
2. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185
3. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. Treatment suitability is determined by your prescribing doctor based on your individual health profile.

© 2026 noah™. All rights reserved.